আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

rowex ltd - darunavir - film-coated tablet - 400 milligram(s) - protease inhibitors; darunavir

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

rowex ltd - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - emtricitabine 200mg;  ;  ;  ;  ; tenofovir alafenamide fumarate 11.2mg equivalent to 10 mg tenofovir alafenamide;   - film coated tablet - 200mg/10mg - active: emtricitabine 200mg         tenofovir alafenamide fumarate 11.2mg equivalent to 10 mg tenofovir alafenamide   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry grey 85f97517 - descovy is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and adolescents aged 12 years and older with body weight at least 35 kg. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of descovy. descovy is not for use in pre-exposure prophylaxis (prep)?.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - emtricitabine 200mg;  ;  ;  ;  ; tenofovir alafenamide fumarate 28mg equivalent to 25 mg tenofovir alafenamide;   - film coated tablet - 200mg/25mg - active: emtricitabine 200mg         tenofovir alafenamide fumarate 28mg equivalent to 25 mg tenofovir alafenamide   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue 85f105057 - descovy is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and adolescents aged 12 years and older with body weight at least 35 kg. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of descovy. descovy is not for use in pre-exposure prophylaxis (prep)?.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - emtricitabine, quantity: 200 mg; tenofovir alafenamide fumarate, quantity: 11.2 mg (equivalent: tenofovir alafenamide, qty 10 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; iron oxide black - treatment of hiv-1 infection: descovy is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25kg. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of descovy (see section 5.1 pharmacodynamic properties).,hiv-1 pre-exposure prophylaxis: descovy is indicated for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in at-risk adults and adolescents weighing at least 35 kg, excluding individuals at risk from receptive vaginal sex.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - emtricitabine, quantity: 200 mg; tenofovir alafenamide fumarate, quantity: 28 mg (equivalent: tenofovir alafenamide, qty 25 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - treatment of hiv-1 infection: descovy is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25kg. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of descovy (see section 5.1 pharmacodynamic properties).,hiv-1 pre-exposure prophylaxis: descovy is indicated for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in at-risk adults and adolescents weighing at least 35 kg, excluding individuals at risk from receptive vaginal sex.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - darunavir, quantity: 800 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; silicon dioxide; magnesium stearate; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - prezcobix, a fixed dose combination of darunavir and cobicistat, is indicated in combination with other antiretroviral agents for the treatment of adult patients with human immunodeficiency virus- 1 (hiv-1) infection in:,- antiretroviral treatment-naive patients,- antiretroviral treatment-experienced patients with no darunavir resistance associated mutations and who have plasma hiv-1 rna <100,000 copies/ml,- antiretroviral treatment-experienced but hiv protease inhibitor-naive patients for whom hiv-1 genotype testing is unavailable (see section 4.2 dose and method of administration)

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

remedyrepack inc. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg - sustiva ® (efavirenz) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. - sustiva is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product. - coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [see warnings and precautions ( 5.1) and drug interactions ( 7.1) ]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to sustiva during pregnancy. physicians are encouraged to register patients by calling the antiretroviral pregnancy registry at 1-800-258-4263. there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efavirenz-containing regimens in th

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - tipranavir - capsule - 250mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - darunavir ethanolate - tablet - 600mg